Stay updated on Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Updated study record dates: Enrollment (Actual) 13 and Study Completion (Actual) 2025-08-21, plus Last Update Posted 2025-10-01. The rest of the study details appear unchanged.
    Difference
    0.3%
    Check dated 2025-11-03T21:32:41.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Core content and status/version information updated: old recruitment/status indicators removed; newer operating status notice and updated dates/revision added.
    Difference
    4%
    Check dated 2025-10-06T06:55:34.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.1%
    Check dated 2025-09-29T03:29:24.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2, indicating a minor content update. The older v3.0.1 tag was removed, and the 'Back to Top' element was deleted.
    Difference
    0.2%
    Check dated 2025-09-14T21:25:20.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-07T17:15:06.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information and facility details, while some previous drug information and related topics have been removed.
    Difference
    6%
    Check dated 2025-08-31T12:10:12.000Z thumbnail image

Stay in the know with updates to Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page.